Mammary tumours are among the most common tumours in dogs and are of interest due to their similarities to human breast tumours. Insulin-like growth factors (IGFs) are considered important in cell growth and development. The aim of this study was to investigate the immunohistochemical expression of IGF-I and IGF-II in benign and malignant canine mammary tumours. In this study, 10 benign and 10 malignant mammary tumours from the archives of the Department of Pathology were used, and five normal breast tissues were used as controls. It was observed that the expression of IGF-I and IGF-II was low to absent in benign tumours and increased in malignant tumours. The expression of IGF-II was higher than that of IGF-I. This study showed that IGF-I and IGF-II can be used as criteria for malignancy in canine mammary tumours. The results also indicate that IGF-I and IGF-II may be used as early diagnostic markers, and their inhibition may be used for the treatment of canine and human mammary tumours in the future.
Baker, S. G. (2000): Identifying combinations of cancer markers for further study as triggers of early intervention. Biometrics 56 ,1082–1087.
Benjamin, S. A., Lee, A. C. and Saunders, W. J. (1999): Classification and behavior of canine mammary epithelial neoplasms based on life-span observations in beagles. Vet. Pathol. 36 ,423–436.
Bergman, D., Halje, M., Nordin, M. and Engström, W. (2013): Insulin-like growth factor 2 in development and disease: a mini-review. Gerontology 59 ,240–249.
Carvalho, M. I., Silva-Carvalho, R., Pires, I., Prada, J., Bianchini, R., Jensen-Jarolim, E. and Queiroga, F. L. (2016): A comparative approach of tumor-associated inflammation in mammary cancer between humans and dogs. Biomed Res. Int. 4917387.
Cassali, G. D. (2013): Comparative mammary oncology: Canine model. BMC Proc. 7 ,Suppl. 2, K6.
Cohen, D., Reif, J. S., Brodey, R. S. and Keiser, H. (1974): Epidemiological analysis of the most prevalent sites and types of canine neoplasia observed in a veterinary hospital. Cancer Res. 34 ,2859–2868.
Concannon, P., Altszuler, N., Hampshire, J., Butler, W. R. and Hansel, W. (1980): Growth hormone, prolactin, and cortisol in dogs developing mammary nodules and an acromegaly-like appearance during treatment with medroxyprogesterone acetate. Endocrinol. 106 ,1173–1177.
Diamandis, E. P. and Yousef, G. M. (2002): Human tissue kallikreins: a family of new cancer biomarkers. Clin. Chem. 48 ,1198–1205.
Engström, W., Shokrai, A., Otte, K., Granerus, M., Gessbo, A., Bierke, P., Madej, A., Sjolund, M. and Ward, A. (1998): Transcriptional regulation and biological significance of the insulin like growth factor II gene. Cell Prolif. 31 ,173–189.
Hawai, S. M., Al Zayer, M., Ali, M. M., Niu, Y., Al Awad, A., Al Jofan, M., Al Jarbou, A. and Al Tuwijri, S. (2013): Dogs: active role model for cancer studies – A review. J. Can. Ther. 4 ,989–995.
Illera, J. C., Pérez-Alenza, M. D., Nieto, A., Jimenez, M. A., Silvana, G., Dunner, S. and Peña, S. (2006): Steroids and receptors in canine mammary cancer. Steroids 71 ,541–548.
Johnston, S. D., Root Kustritz, M. V. and Olson, P. N. S. (2001): Disorders of the mammary glands of the bitch. In: Johnston, S. D., Root Kustritz, M. V. and Olson, P. N. S. (eds) Canine and Feline Theriogenology. 1st edition. Saunders, Philadelphia. pp. 243–256.
Kleinberg, D. L. (1998): Role of IGF-I in normal mammary development. Breast Cancer Res. Treat. 47, 201–208.
Klopfleisch, R., Hvid, H., Klose, P., da Costa, A. and Gruber, A.D. (2010): Insulin receptor is expressed in normal canine mammary gland and benign adenomas but decreased in metastatic canine mammary carcinomas similar to human breast cancer. Vet. Comp. Oncol. 8 ,293–301.
Lana, S. E., Ruttemans, G. R. and Withrow, S. J. (2007): Tumors of the mammary gland. In: Withrow, S. J. and Vail, D. M. (eds) Small Animal Clinical Oncology. Saunders Elsevier, St. Louis, Missouri. pp. 619–636.
Mancarella, C. and Scotlandi, K. (2018): IGF system in sarcomas: a crucial pathway with many unknowns to exploit for therapy. J. Mol. Endocrinol. 61 ,T45–T60.
Misdorp, W. (2002): Tumors of the mammary gland. In: Meuten, D. J. (ed.) Tumors in Domestic Animals. State University of California, California. pp. 575–606.
Misdorp, W., Else, R. W. and Hellemn, E. (1999): WHO Histological Classification of Mammary Tumors of the Dog and Cat. Definitions and Explanatory Notes. Armed Forces Institute of Pathology, Washington. pp. 18–27.
Mol, J. A. (2013): Comparative breast cancer research – Lessons from companion animals. BMC Proc. 7 ,Suppl. 2, K9.
Mol, J. A., Lantinga-van Leeuwen, I. S., van Garderen, E., Selman, P. J., Oosterlaken-Dijksterhuis, M. A., Schalken, J. A. and Rijnberk, A. (1999): Mammary growth hormone and tumourigenesis – Lessons from the dog. Vet. Q. 21 ,111–115.
Mol, J. A., Selman, P. J., Sprang, E. P., van Neck, J. W. and Oosterlaken-Dijksterhuis, M. A. (1997): The role of progestins, insulin-like growth factor (IGF) and IGF-binding proteins in the normal and neoplastic mammary gland of the bitch: a review. J. Reprod. Fertil. Suppl. 51 ,339–344.
Mol, J. A., van Garderen, E., Rutteman, G. R. and Rijnberk, A. (1996): New insights in the molecular mechanism of progestin-induced proliferation of mammary epithelium: induction of the local biosynthesis of growth hormone (GH) in the mammary glands of dogs, cats and humans. J. Steroid Biochem. Mol. Biol. 57 ,67–71.
Mol, J. A., van Garderen, E., Selman, P. J., Wolfswinkel, J., Rijnberk, A. and Rutteman, G. R. (1995): Growth hormone mRNA in mammary gland tumors of dogs and cats. J. Clin. Invest. 95 ,2028–2034.
Nerurkar, V. R., Chitale, A. R., Jalnapurkar, B. V., Naik, S. N. and Lalitha, V. S. (1989): Comparative pathology of canine mammary tumors. J. Comp. Pathol. 101 ,389–397.
Pepe, M. S., Etzioni, R., Feng, Z., Potter, J. D., Thompson, M. L., Thornquist, M., Winget, M. and Yasui, Y. (2001): Phases of biomarker development for early detection of cancer. J. Natl Cancer Inst. 93 ,1054–1061.
Queiroga, F. L., Pérez-Alenza, M. D., Silvan, G., Peña, L., Lopes, C. and Illera, J. C. (2005): Role of steroid hormones and prolactin in canine mammary cancer. J. Steroid Biochem. Mol. Biol. 94 ,181–187.
Queiroga, F. L., Pérez-Alenza, M. D., Silvan, G., Peña, L., Lopes, C. and Illera, J.C. (2008): Crosstalk between GH/IGF-I axis and steroid hormones (progesterone, 17β-estradiol) in canine mammary tumours. J. Steroid Biochem. Mol. Biol. 110 ,76–82.
Queiroga, F. L., Pérez-Alenza, M. D., Silvan, G., Peña, L., Lopes, C. and Illera, J. C. (2010): Serum and intratumoural GH and IGF-I concentrations: Prognostic factors in the outcome of canine mammary cancer. Res. Vet. Sci. 89 ,396–403.
Queiroga, F. L., Raposo, T. and Carvalho, M. I. (2011): Canine mammary tumours as a model to study human breast cancer: Most recent findings. In Vivo 25 ,455–466.
Samani, A. A., Yakar, S., LeRoith, D. and Brodt, P. (2007): The role of the IGF system in cancer growth and metastasis: overview and recent insights. Endocrine Rev. 28 ,20–47.
Selman, P. J., Mol, J. A., Rutteman, G. R. and Rijnberk, A. (1994): Progestin treatment in the dog. I. Effects on growth hormone, insulin-like growth factor I and glucose homeostasis. Eur. J. Endocrinol. 131 ,413–421.
Sorenmo, K. U., Kristiansen, V. M., Cofone, M. A., Shofer, F. S., Been, A. M., Langeland, M., Mongel, C. M, Grondahl, A. M., Teige, J. and Goldschmidt, M. H. (2009): Canine mammary gland tumors: A histological continuum from benign to malignant; clinical and histological evidence. Vet. Comp. Oncol. 7 ,162–172.
Sultan, F. and Ganaie, B. (2018): Comparative oncology: Integrating human and veterinary medicine. Open Vet. J. 8 ,25–34.
Van Garderen, E., Van der Poel, H. J. A., Swennenhuis, J. F., Wissink, E. H. J., Rutteman, G. R., Hellmen, E., Mol. J. A. and Schalken, J. A. (1999): Expression and molecular characterization of the growth hormone receptor in canine mammary tissue and mammary tumors. Endocrinology 140 ,5907–5914.